Par Pharmaceutical names new CFO, COO
-
- June
- 7
Par Pharmaceutical Cos. announced today that Veronica A. Lubatkin has succeeded Gerard A. Martino as chief financial officer, while Martino has been named the company’s chief operating officer.
Lubatkin joined the company a year ago as controller. Martino was hired as CFO in March 2006, four months before Par announced it that it would restate its yearly earnings for 2004 and 2005 and the first quarter of 2006.
Par, which has major operations in Chestnut Ridge, announced in March that it has filed amended yearly reports for 2004 and 2005. And in a filing last month with the Securities and Exchange Commission, the company said it is in the process of preparing an amended statement for the first quarter of 2006.
The generic-drug maker is also restating and preparing statements for the second and third quarters of 2006, as well as the year ended 2006, Par said in the filing. In addition, Par told the SEC that it needs additional time to prepare its first quarter 2007 financial statement.
This entry was posted
on Thursday, June 7th, 2007 at 5:59 pm by David Schepp.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
